Sex differences in TTC12/ANKK1 haplotype associations with daily tobacco smoking in Black and White Americans.

INTRODUCTION The 11q23.1 genomic region has been associated with nicotine dependence in Black and White Americans. METHODS By conducting linkage disequilibrium analyses of 7 informative single nucleotide polymorphisms (SNPs) within the tetratricopeptide repeat domain 12 (TTC12)/ankyrin repeat and kinase containing 1 (ANKK1)/dopamine (D2) receptor gene cluster, we identified haplotype block structures in 270 Black and 368 White (n = 638) participants, from the Baltimore Epidemiologic Catchment Area cohort study, spanning the TTC12 and ANKK1 genes consisting of three SNPs (rs2303380-rs4938015-rs11604671). Informative haplotypes were examined for sex-specific associations with daily tobacco smoking initiation and cessation using longitudinal data from 1993-1994 and 2004-2005 interviews. RESULTS There was a Haplotype x Sex interaction such that Black men possessing the GTG haplotype who were smokers in 1993-2004 were more likely to have stopped smoking by 2004-2005 (55.6% GTG vs. 22.0% other haplotypes), while Black women were less likely to have quit smoking if they possessed the GTG (20.8%) versus other haplotypes (24.0%; p = .028). In Whites, the GTG haplotype (vs. other haplotypes) was associated with lifetime history of daily smoking (smoking initiation; odds ratio = 1.6; 95% CI = 1.1-2.4; p = .013). Moreover, there was a Haplotype x Sex interaction such that there was higher prevalence of smoking initiation with GTG (77.6%) versus other haplotypes (57.0%; p = .043). DISCUSSION In 2 different ethnic American populations, we observed man-woman variation in the influence of the rs2303380-rs4938015-rs11604671 GTG haplotype on smoking initiation and cessation. These results should be replicated in larger cohorts to establish the relationship among the rs2303380-rs4938015-rs11604671 haplotype block, sex, and smoking behavior.

[1]  D. Hatsukami,et al.  Race and nicotine replacement treatment outcomes among low-income smokers. , 2008, American journal of preventive medicine.

[2]  Hongyu Zhao,et al.  Haplotypic variants in DRD2, ANKK1, TTC12, and NCAM1 are associated with comorbid alcohol and drug dependence. , 2008, Alcoholism, clinical and experimental research.

[3]  D. Kendzor,et al.  Socioeconomic Status, Negative Affect, and Modifiable Cancer Risk Factors in African-American Smokers , 2008, Cancer Epidemiology Biomarkers & Prevention.

[4]  S. David,et al.  Genetic variation in the dopamine pathway and smoking cessation. , 2008, Pharmacogenomics.

[5]  Francis J McMahon,et al.  Association study of Wnt signaling pathway genes in bipolar disorder. , 2008, Archives of general psychiatry.

[6]  L. Bierut,et al.  Racial/Ethnic Disparities in the Use of Nicotine Replacement Therapy and Quit Ratios in Lifetime Smokers Ages 25 to 44 Years , 2008, Cancer Epidemiology Biomarkers & Prevention.

[7]  John Scott,et al.  Sex differences in long-term smoking cessation rates due to nicotine patch. , 2008, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[8]  S. L. Yee,et al.  Adult Tobacco Use Among Racial and Ethnic Groups Living in the United States, 2002–2005 , 2008, Preventing chronic disease.

[9]  Caryn Lerman,et al.  Molecular genetics of successful smoking cessation: convergent genome-wide association study results. , 2008, Archives of general psychiatry.

[10]  P. Zandi,et al.  Participant Characteristics That Influence Consent for Genetic Research in a Population-Based Survey: The Baltimore Epidemiologic Catchment Area Follow-Up , 2008, Public Health Genomics.

[11]  Richard A. Brown,et al.  Bupropion efficacy for smoking cessation is influenced by the DRD2 Taq1A polymorphism: analysis of pooled data from two clinical trials. , 2007, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[12]  Hongyu Zhao,et al.  Association of haplotypic variants in DRD2, ANKK1, TTC12 and NCAM1 to alcohol dependence in independent case control and family samples. , 2007, Human molecular genetics.

[13]  W. Eaton,et al.  Prevalence and incidence of depressive disorder: the Baltimore ECA follow‐up, 1981–2004 , 2007, Acta psychiatrica Scandinavica.

[14]  M. Fine,et al.  Volume of Tobacco Advertising in African American Markets: Systematic Review and Meta-Analysis , 2007, Public health reports.

[15]  Richard A. Brown,et al.  Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation. , 2007, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[16]  V. Willour,et al.  Genome-wide linkage scan of 98 bipolar pedigrees and analysis of clinical covariates , 2007, Molecular Psychiatry.

[17]  V. Willour,et al.  SNP fine mapping of chromosome 8q24 in bipolar disorder , 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[18]  G. Swan,et al.  Joint effect of dopaminergic genes on likelihood of smoking following treatment with bupropion SR. , 2007, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[19]  K. Brady,et al.  Haplotype spanning TTC12 and ANKK1, flanked by the DRD2 and NCAM1 loci, is strongly associated to nicotine dependence in two distinct American populations. , 2006, Human molecular genetics.

[20]  A. Zeileis.  Object-oriented Computation of Sandwich Estimators , 2006 .

[21]  Jinko Graham,et al.  hapassoc: Software for Likelihood Inference of Trait Associations with SNP Haplotypes and Other Attributes , 2006 .

[22]  J. Beuten,et al.  Progress in searching for susceptibility loci and genes for smoking‐related behaviour , 2004, Clinical genetics.

[23]  S. David,et al.  Are there sex differences in transdermal nicotine replacement therapy patch efficacy? A meta-analysis. , 2004, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[24]  M. Munafo,et al.  The genetic basis for smoking behavior: a systematic review and meta-analysis. , 2004, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[25]  A. Cepeda-Benito,et al.  Meta-analysis of the efficacy of nicotine replacement therapy for smoking cessation: differences between men and women. , 2004, Journal of consulting and clinical psychology.

[26]  M. Neville,et al.  Identification and characterization of ANKK1: A novel kinase gene closely linked to DRD2 on chromosome band 11q23.1 , 2004, Human mutation.

[27]  M. Munafo,et al.  Effectiveness of nicotine patches in relation to genotype in women versus men: randomised controlled trial , 2004, BMJ : British Medical Journal.

[28]  R. Walton,et al.  Genetic variation in dopaminergic pathways and short-term effectiveness of the nicotine patch. , 2004, Pharmacogenetics.

[29]  M. Katoh,et al.  Identification and characterization of TPARM gene in silico. , 2003, International journal of oncology.

[30]  L. Epstein,et al.  Effects of dopamine transporter and receptor polymorphisms on smoking cessation in a bupropion clinical trial. , 2003, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[31]  L. Epstein,et al.  Pharmacogenetic investigation of smoking cessation treatment. , 2002, Pharmacogenetics.

[32]  D. Abrous,et al.  Nicotine Self-Administration Impairs Hippocampal Plasticity , 2002, The Journal of Neuroscience.

[33]  E. Sellers,et al.  Gender differences in tobacco smoking: higher relative exposure to smoke than nicotine in women. , 2002, Journal of women's health & gender-based medicine.

[34]  W. Eaton,et al.  A comparison of self-report and clinical diagnostic interviews for depression: diagnostic interview schedule and schedules for clinical assessment in neuropsychiatry in the Baltimore epidemiologic catchment area follow-up. , 2000, Archives of general psychiatry.

[35]  M. Bleavins,et al.  High throughput genotyping for the detection of a single nucleotide polymorphism in NAD(P)H quinone oxidoreductase (DT diaphorase) using TaqMan probes. , 1999, Molecular pathology : MP.

[36]  D StClair,et al.  -141 C del/ins polymorphism of the dopamine receptor 2 gene is associated with schizophrenia in a British population. , 1999, American journal of medical genetics.

[37]  M. Nöthen,et al.  Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers , 1999, Molecular Psychiatry.

[38]  D. Abrams,et al.  Individual differences in cue reactivity among smokers trying to quit: effects of gender and cue type. , 1998, Addictive behaviors.

[39]  J. Wu,et al.  D2 dopamine receptor polymorphism and brain regional glucose metabolism. , 1997, American journal of medical genetics.

[40]  P. Sokoloff,et al.  Dopamine-related genes and their relationships to monoamine metabolites in CSF , 1996, Biological Psychiatry.

[41]  K. Perkins,et al.  Influence of training dose on nicotine discrimination in humans , 1996, Psychopharmacology.

[42]  L. Kozlowski,et al.  The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. , 1991, British journal of addiction.

[43]  E P Noble,et al.  Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. , 1991, Archives of general psychiatry.

[44]  D. Grandy,et al.  The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP. , 1989, American journal of human genetics.

[45]  M. Mattei,et al.  Localization of the human NCAM gene to band q23 of chromosome 11: the third gene coding for a cell interaction molecule mapped to the distal portion of the long arm of chromosome 11 , 1986, The Journal of cell biology.

[46]  D. Blazer,et al.  The NIMH Epidemiologic Catchment Area program. Historical context, major objectives, and study population characteristics. , 1984, Archives of general psychiatry.

[47]  D. Lawlor,et al.  Association of the DRD2 gene Taq1A polymorphism and smoking behavior: a meta-analysis and new data. , 2009, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[48]  L. Epstein,et al.  Role of Functional Genetic Variation in the Dopamine D2 Receptor (DRD2) in Response to Bupropion and Nicotine Replacement Therapy for Tobacco Dependence: Results of Two Randomized Clinical Trials , 2006, Neuropsychopharmacology.

[49]  G. Swan,et al.  Dopamine receptor DRD2 genotype and smoking cessation outcome following treatment with bupropion SR , 2005, The Pharmacogenomics Journal.

[50]  Ming D. Li,et al.  A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins. , 2003, Addiction.

[51]  K. Perkins.  Smoking Cessation in Women , 2001, CNS drugs.

[52]  K. Perkins.  Nicotine self-administration. , 1999, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[53]  A. Blum,et al.  Tobacco Use Among U.S. Racial/Ethnic Minority Groups-African Americans, American Indians and Alaska Natives, Asian Americans and Pacific Islanders, and Hispanics: A Report of the Surgeon General , 1998 .